Astrocytic glutamatergic transmission and its implications in neurodegenerative disorders

S Satarker, SL Bojja, PC Gurram, J Mudgal, D Arora… - Cells, 2022 - mdpi.com
Several neurodegenerative disorders involve impaired neurotransmission, and
glutamatergic neurotransmission sets a prototypical example. Glutamate is a predominant …

[HTML][HTML] The putative role of neuroinflammation in the complex pathophysiology of migraine: from bench to bedside

L Biscetti, E Cresta, LM Cupini, P Calabresi… - Neurobiology of …, 2023 - Elsevier
The implications of neurogenic inflammation and neuroinflammation in the pathophysiology
of migraine have been clearly demonstrated in preclinical migraine models involving several …

P2X7R/NLRP3 signaling pathway-mediated pyroptosis and neuroinflammation contributed to cognitive impairment in a mouse model of migraine

Y Wang, Z Shan, L Zhang, S Fan, Y Zhou, L Hu… - The journal of headache …, 2022 - Springer
Migraine is the second most common form of headache disorder and the second leading
cause of disability worldwide. Cognitive symptoms ranked second resulting in migraine …

Experimental and clinical investigation of cytokines in migraine: a narrative review

G Yamanaka, K Hayashi, N Morishita… - International Journal of …, 2023 - mdpi.com
The role of neuroinflammation in the pathophysiology of migraines is increasingly being
recognized, and cytokines, which are important endogenous substances involved in …

Src family kinases facilitate the crosstalk between CGRP and cytokines in sensitizing trigeminal ganglion via transmitting CGRP receptor/PKA pathway

L Nie, K Sun, Z Gong, H Li, JP Quinn, M Wang - Cells, 2022 - mdpi.com
The communication between calcitonin gene-related peptide (CGRP) and cytokines plays a
prominent role in maintaining trigeminal ganglion (TG) and trigeminovascular sensitization …

Unraveling the interplay of neuroinflammatory signaling between parenchymal and meningeal cells in migraine headache

T Dalkara, Z Kaya, ŞE Erdener - The Journal of Headache and Pain, 2024 - Springer
Background The initiation of migraine headaches and the involvement of neuroinflammatory
signaling between parenchymal and meningeal cells remain unclear. Experimental …

Beyond seizure control: treating comorbidities in epilepsy via targeting of the P2X7 receptor

B Gil, J Smith, Y Tang, P Illes, T Engel - International Journal of Molecular …, 2022 - mdpi.com
Epilepsy is one of the most common chronic diseases of the central nervous system (CNS).
Treatment of epilepsy remains, however, a clinical challenge with over 30% of patients not …

Purinergic P2X7 receptor as a potential therapeutic target in depression

W Qi, X Jin, W Guan - Biochemical Pharmacology, 2024 - Elsevier
The elaborate mechanisms of depression have always been a research hotspot in recent
years, and the pace of research has never ceased. The P2X7 receptor (P2X7R) belongs to …

Transcranial magnetic stimulation as a therapy for migraine: An overview of systematic reviews

M Shen, C Li, X Wei, L Zhang, Y Li, H Wu… - Journal of Pain …, 2023 - Taylor & Francis
Introduction This overview of systematic reviews (SRs) systematically collected, evaluated,
and combined the evidence for migraine treatment with transcranial magnetic stimulation …

Role of the P2× 7 receptor in neurodegenerative diseases and its pharmacological properties

Z Hu, Y Luo, J Zhu, D Jiang, Z Luo, L Wu, J Li, S Peng… - Cell & Bioscience, 2023 - Springer
Neurodegenerative diseases seriously affect patients' physical and mental health, reduce
their quality of life, and impose a heavy burden on society. However, their treatment remains …